The information in this preliminary pricing
supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to
buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated July 17, 2024
July , 2024 |
Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg)
JPMorgan Chase Financial Company LLC
Structured Investments
Callable Contingent Interest Notes Linked to the Least
Performing of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index due
July 20, 2028
Fully and Unconditionally Guaranteed by JPMorgan Chase
& Co.
| · | The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date, for which the closing
level of each of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index,
which we refer to as the Indices, is greater than or equal to 70.00% of its Strike Value, which we refer to as an Interest Barrier. |
| · | The notes may be redeemed early, in whole but not in part, at our option on any of the Interest Payment Dates (other than the first,
second and final Interest Payment Dates). |
| · | The earliest date on which the notes may be redeemed early is October 21, 2024. |
| · | Investors should be willing to accept the risk of losing some or all of their principal and the risk that no Contingent Interest Payment
may be made with respect to some or all Review Dates. |
| · | Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent
Interest Payments. |
| · | The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial,
the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the
credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. |
| · | Payments on the notes are not linked to a basket composed of the Indices. Payments on the notes are linked to the performance of each
of the Indices individually, as described below. |
| · | Minimum denominations of $1,000 and integral multiples thereof |
| · | The notes are expected to price on or about July 18, 2024 (the “Pricing Date”) and are expected to settle on or about
July 23, 2024. The Strike Value of each Index has been determined by reference to the closing level of that Index on July 16, 2024
and not by reference to the closing level of that Index on the Pricing Date. |
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk
Factors” beginning on page PS-11 of the accompanying product supplement and “Selected Risk Considerations” beginning
on page PS-5 of this pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any
representation to the contrary is a criminal offense.
|
Price to Public (1) |
Fees and Commissions (2) |
Proceeds to Issuer |
Per note |
$1,000 |
$ |
$ |
Total |
$ |
$ |
$ |
(1) See “Supplemental Use of Proceeds” in
this pricing supplement for information about the components of the price to public of the notes.
(2) J.P. Morgan Securities LLC, which we refer to as
JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated or unaffiliated
dealers. In no event will these selling commissions exceed $3.50 per $1,000 principal amount note. See “Plan of Distribution (Conflicts
of Interest)” in the accompanying product supplement. |
If the notes priced today, the estimated value of the notes would
be approximately $977.90 per $1,000 principal amount note. The estimated value of the notes, when the terms of the notes are set, will
be provided in the pricing supplement and will not be less than $950.00 per $1,000 principal amount note. See “The Estimated Value
of the Notes” in this pricing supplement for additional information.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
Pricing supplement to product supplement no. 4-I dated April 13, 2023,
underlying supplement no. 1-I dated April 13, 2023,
the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024
Key Terms
Issuer:
JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase &
Co.
Guarantor:
JPMorgan Chase & Co.
Indices:
The Russell 2000® Index (Bloomberg
ticker: RTY), the EURO STOXX 50® Index (Bloomberg ticker: SX5E) and the MSCI Emerging Markets Index (Bloomberg ticker:
MXEF)
Contingent
Interest Payments: If the notes have not been previously redeemed early and the closing level of each Index on any Review Date
is greater than or equal to its Interest Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount
note a Contingent Interest Payment equal to at least $8.3333 (equivalent to a Contingent Interest Rate of at least 10.00% per annum, payable
at a rate of at least 0.83333% per month) (to be provided in the pricing supplement).
If the closing level of any Index on any Review Date is less than
its Interest Barrier, no Contingent Interest Payment will be made with respect to that Review Date.
Contingent
Interest Rate: At least 10.00% per annum, payable at a rate of at least 0.83333% per month
(to be provided in the pricing supplement)
Interest Barrier: With respect
to each Index, 70.00% of its Strike Value, which is 1,584.5718 for the Russell 2000® Index, 3,463.481 for the EURO STOXX
50® Index and 782.166 for the MSCI Emerging Markets Index
Trigger Value: With respect
to each Index, 65.00% of its Strike Value, which is 1,471.3881 for the Russell 2000® Index, 3,216.0895 for the EURO STOXX
50® Index and 726.297 for the MSCI Emerging Markets Index
Strike
Date: July 16, 2024
Pricing
Date: On or about July 18, 2024
Original
Issue Date (Settlement Date): On or about July 23, 2024
Review
Dates*: August 16, 2024, September 16, 2024, October 16, 2024, November 18, 2024, December 16, 2024, January 16, 2025, February
18, 2025, March 17, 2025, April 16, 2025, May 16, 2025, June 16, 2025, July 16, 2025, August 18, 2025, September 16, 2025, October 16,
2025, November 17, 2025, December 16, 2025, January 16, 2026, February 17, 2026, March 16, 2026, April 16, 2026, May 18, 2026, June 16,
2026, July 16, 2026, August 17, 2026, September 16, 2026, October 16, 2026, November 16, 2026, December 16, 2026, January 19, 2027, February
16, 2027, March 16, 2027, April 16, 2027, May 17, 2027, June 16, 2027, July 16, 2027, August 16, 2027, September 16, 2027, October 18,
2027, November 16, 2027, December 16, 2027, January 18, 2028, February 16, 2028, March 16, 2028, April 18, 2028, May 16, 2028, June 16,
2028 and July 17, 2028 (final Review Date)
Interest
Payment Dates*: August 21, 2024, September 19, 2024, October 21, 2024, November 21, 2024, December 19, 2024, January 22, 2025,
February 21, 2025, March 20, 2025, April 22, 2025, May 21, 2025, June 20, 2025, July 21, 2025, August 21, 2025, September 19, 2025, October
21, 2025, November 20, 2025, December 19, 2025, January 22, 2026, February 20, 2026, March 19, 2026, April 21, 2026, May 21, 2026, June
22, 2026, July 21, 2026, August 20, 2026, September 21, 2026, October 21, 2026, November 19, 2026, December 21, 2026, January 22, 2027,
February 19, 2027, March 19, 2027, April 21, 2027, May 20, 2027, June 22, 2027, July 21, 2027, August 19, 2027, September 21, 2027, October
21, 2027, November 19, 2027, December 21, 2027, January 21, 2028, February 22, 2028, March 21, 2028, April 21, 2028, May 19, 2028, June
22, 2028 and the Maturity Date
Maturity
Date*: July 20, 2028
|
Early Redemption:
We, at our election, may redeem the notes early, in whole but not in
part, on any of the Interest Payment Dates (other than the first, second and final Interest Payment Dates) at a price, for each $1,000
principal amount note, equal to (a) $1,000 plus (b) the Contingent Interest Payment, if any, applicable to the immediately preceding
Review Date. If we intend to redeem your notes early, we will deliver notice to The Depository Trust Company, or DTC, at least three business
days before the applicable Interest Payment Date on which the notes are redeemed early.
Payment at Maturity:
If the notes have not been redeemed early and the Final Value of each
Index is greater than or equal to its Trigger Value, you will receive a cash payment at maturity, for each $1,000 principal amount note,
equal to (a) $1,000 plus (b) the Contingent Interest Payment, if any, applicable to the final Review Date.
If the notes have not been redeemed early and the Final Value of any
Index is less than its Trigger Value, your payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 + ($1,000 × Least Performing Index Return)
If the notes have not been redeemed early and the Final Value of any
Index is less than its Trigger Value, you will lose more than 35.00% of your principal amount at maturity and could lose all of your principal
amount at maturity.
Least Performing Index: The
Index with the Least Performing Index Return
Least Performing Index Return: The
lowest of the Index Returns of the Indices
Index Return:
With respect to each Index,
(Final Value – Strike Value)
Strike Value
Strike
Value: With respect to each Index, the closing level of that Index on the Strike Date, which was 2,263.674 for the Russell
2000® Index, 4,947.83 for the EURO STOXX 50® Index and 1,117.38 for the MSCI Emerging Markets Index. The
Strike Value of each Index is not the closing level of that Index on the Pricing Date.
Final
Value: With respect to each Index, the closing level of that Index on the final Review Date
* Subject to postponement in the event of a market disruption event and
as described under “General Terms of Notes — Postponement of a Determination Date — Notes Linked to Multiple Underlyings”
and “General Terms of Notes — Postponement of a Payment Date” in the accompanying product supplement or early acceleration
in the event of a change-in-law event as described under “General Terms of Notes — Consequences of a Change-in-Law Event”
in the accompanying product supplement and “Selected Risk Considerations — Risks Relating to the Notes Generally — We
May Accelerate Your Notes If a Change-in-Law Event Occurs” in this pricing supplement |
PS-1
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
Supplemental
Terms of the Notes
Any values of the Indices, and any values derived therefrom,
included in this pricing supplement may be corrected, in the event of manifest error or inconsistency, by amendment of this pricing supplement
and the corresponding terms of the notes. Notwithstanding anything to the contrary in the indenture governing the notes, that amendment
will become effective without consent of the holders of the notes or any other party.
How the Notes
Work
Payments in Connection with the
First and Second Review Dates
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_002.jpg)
Payments in Connection with Review Dates
(Other than the First, Second and Final Review Dates)
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_003.jpg)
PS-2
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
Payment at Maturity If the Notes Have
Not Been Redeemed Early
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_004.jpg)
Total Contingent Interest Payments
The table below illustrates the hypothetical total Contingent
Interest Payments per $1,000 principal amount note over the term of the notes based on a hypothetical Contingent Interest Rate of 10.00%
per annum, depending on how many Contingent Interest Payments are made prior to early redemption or maturity. The actual Contingent Interest
Rate will be provided in the pricing supplement and will be at least 10.00% per annum (payable at a rate of at least 0.83333% per month).
Number of Contingent
Interest Payments |
Total Contingent Interest
Payments |
48 |
$400.0000 |
47 |
$391.6667 |
46 |
$383.3333 |
45 |
$375.0000 |
44 |
$366.6667 |
43 |
$358.3333 |
42 |
$350.0000 |
41 |
$341.6667 |
40 |
$333.3333 |
39 |
$325.0000 |
38 |
$316.6667 |
37 |
$308.3333 |
36 |
$300.0000 |
35 |
$291.6667 |
34 |
$283.3333 |
33 |
$275.0000 |
32 |
$266.6667 |
31 |
$258.3333 |
30 |
$250.0000 |
29 |
$241.6667 |
28 |
$233.3333 |
27 |
$225.0000 |
26 |
$216.6667 |
25 |
$208.3333 |
24 |
$200.0000 |
23 |
$191.6667 |
22 |
$183.3333 |
PS-3
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
21 |
$175.0000 |
20 |
$166.6667 |
19 |
$158.3333 |
18 |
$150.0000 |
17 |
$141.6667 |
16 |
$133.3333 |
15 |
$125.0000 |
14 |
$116.6667 |
13 |
$108.3333 |
12 |
$100.0000 |
11 |
$91.6667 |
10 |
$83.3333 |
9 |
$75.0000 |
8 |
$66.6667 |
7 |
$58.3333 |
6 |
$50.0000 |
5 |
$41.6667 |
4 |
$33.3333 |
3 |
$25.0000 |
2 |
$16.6667 |
1 |
$8.3333 |
0 |
$0.0000 |
Hypothetical
Payout Examples
The following examples illustrate payments on the notes
linked to three hypothetical Indices, assuming a range of performances for the hypothetical Least Performing Index on the Review Dates.
Each hypothetical payment set forth below assumes that the closing level of each Index that is not the Least Performing Index on each
Review Date is greater than or equal to its Strike Value (and therefore its Interest Barrier and Trigger Value).
The hypothetical payments set forth below assume the
following:
| · | the notes have not been redeemed early; |
| · | a Strike Value for the Least Performing Index of 100.00; |
| · | an Interest Barrier for the Least Performing Index of 70.00 (equal to 70.00% of its hypothetical Strike Value); |
| · | a Trigger Value for the Least Performing Index of 65.00 (equal to 65.00% of its hypothetical Strike Value); and |
| · | a Contingent Interest Rate of 10.00% per annum. |
The hypothetical Strike Value of the Least Performing
Index of 100.00 has been chosen for illustrative purposes only and does not represent the actual Strike Value of any Index. The actual
Strike Value of each Index is the closing level of that Index on the Strike Date and is specified under “Key Terms — Strike
Value” in this pricing supplement. For historical data regarding the actual closing levels of each Index, please see the historical
information set forth under “The Indices” in this pricing supplement.
Each hypothetical payment set forth below is for illustrative
purposes only and may not be the actual payment applicable to a purchaser of the notes. The numbers appearing in the following examples
have been rounded for ease of analysis.
Example 1 — Notes have NOT been redeemed early
and the Final Value of the Least Performing Index is greater than or equal to its Trigger Value and its Interest Barrier.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
95.00 |
$8.3333 |
Second Review Date |
85.00 |
$8.3333 |
Third through Forty-Seventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
90.00 |
$1,008.3333 |
PS-4
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
|
Total Payment |
$1,025.00 (2.50% return) |
Because the notes have not been redeemed
early and the Final Value of the Least Performing Index is greater than or equal to its Trigger Value and its Interest Barrier, the payment
at maturity, for each $1,000 principal amount note, will be $1,008.3333 (or $1,000 plus the
Contingent Interest Payment applicable to the final Review Date). When added to the Contingent Interest Payments received with respect
to the prior Review Dates, the total amount paid, for each $1,000 principal amount note, is $1,025.00.
Example 2 — Notes have NOT been redeemed early
and the Final Value of the Least Performing Index is less than its Interest Barrier but is greater than or equal to its Trigger Value.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
95.00 |
$8.3333 |
Second Review Date |
80.00 |
$8.3333 |
Third through Forty-Seventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
65.00 |
$1,000.00 |
|
Total Payment |
$1,016.6667 (1.66667% return) |
Because the notes have not been redeemed early and
the Final Value of the Least Performing Index is less than its Interest Barrier but is greater than or equal to its Trigger Value, the
payment at maturity, for each $1,000 principal amount note, will be $1,000.00. When added to the Contingent Interest Payments received
with respect to the prior Review Dates, the total amount paid, for each $1,000 principal amount note, is $1,016.6667.
Example
3 — Notes have NOT been redeemed early and the Final Value of the Least Performing Index is less than its Trigger Value.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
40.00 |
$0 |
Second Review Date |
45.00 |
$0 |
Third through Forty-Seventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
40.00 |
$400.00 |
|
Total Payment |
$400.00 (-60.00% return) |
Because the notes have not been redeemed early, the
Final Value of the Least Performing Index is less than its Trigger Value and the Least Performing Index Return is -60.00%, the payment
at maturity will be $400.00 per $1,000 principal amount note, calculated as follows:
$1,000 + [$1,000 × (-60.00%)] = $400.00
The hypothetical returns and hypothetical payments
on the notes shown above apply only if you hold the notes for their entire term. These hypotheticals do not reflect the fees or
expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns
and hypothetical payments shown above would likely be lower.
Selected
Risk Considerations
An investment in the notes involves significant risks.
These risks are explained in more detail in the “Risk Factors” sections of the accompanying prospectus supplement and product
supplement and in Annex A to the accompanying prospectus addendum.
Risks Relating to the Notes Generally
| · | YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS — |
The notes do not guarantee any return of principal.
If the notes have not been redeemed early and the Final Value of any Index is less than its Trigger Value, you will lose 1% of the principal
amount of your notes for every 1% that the Final Value of the Least Performing Index is less than its Strike Value. Accordingly, under
these circumstances, you will lose more than 35.00% of your principal amount at maturity and could lose all of your principal amount at
maturity.
PS-5
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
| · | THE NOTES DO NOT GUARANTEE THE PAYMENT OF INTEREST AND MAY NOT PAY ANY INTEREST AT ALL — |
If the notes have not been redeemed early, we
will make a Contingent Interest Payment with respect to a Review Date only if the closing level of each Index on that Review Date is greater
than or equal to its Interest Barrier. If the closing level of any Index on that Review Date is less than its Interest Barrier, no Contingent
Interest Payment will be made with respect to that Review Date. Accordingly, if the closing level of any Index on each Review Date is
less than its Interest Barrier, you will not receive any interest payments over the term of the notes.
| · | CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN CHASE & CO. — |
Investors are dependent on our and JPMorgan
Chase & Co.’s ability to pay all amounts due on the notes. Any actual or potential change in our or JPMorgan Chase & Co.’s
creditworthiness or credit spreads, as determined by the market for taking that credit risk, is likely to adversely affect the value of
the notes. If we and JPMorgan Chase & Co. were to default on our payment obligations, you may not receive any amounts owed to you
under the notes and you could lose your entire investment.
| · | AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS — |
As a finance subsidiary of JPMorgan Chase &
Co., we have no independent operations beyond the issuance and administration of our securities and the collection of intercompany obligations.
Aside from the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of JPMorgan
Chase & Co. to make payments under loans made by us to JPMorgan Chase & Co. or under other intercompany agreements. As a result,
we are dependent upon payments from JPMorgan Chase & Co. to meet our obligations under the notes. We are not a key operating subsidiary
of JPMorgan Chase & Co. and in a bankruptcy or resolution of JPMorgan Chase & Co. we are not expected to have sufficient resources
to meet our obligations in respect of the notes as they come due. If JPMorgan Chase & Co. does not make payments to us and we are
unable to make payments on the notes, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee
will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co. For more information,
see the accompanying prospectus addendum.
| · | THE APPRECIATION POTENTIAL OF THE NOTES IS LIMITED TO THE SUM OF ANY CONTINGENT INTEREST PAYMENTS THAT MAY BE PAID OVER THE TERM
OF THE NOTES, |
regardless of any appreciation of any Index,
which may be significant. You will not participate in any appreciation of any Index.
| · | YOU ARE EXPOSED TO THE RISK OF DECLINE IN THE LEVEL OF EACH INDEX — |
Payments on the notes are not linked to a basket
composed of the Indices and are contingent upon the performance of each individual Index. Poor performance by any of the Indices over
the term of the notes may negatively affect whether you will receive a Contingent Interest Payment on any Interest Payment Date and your
payment at maturity and will not be offset or mitigated by positive performance by any other Index.
| · | YOUR PAYMENT AT MATURITY WILL BE DETERMINED BY THE LEAST PERFORMING INDEX. |
| · | THE BENEFIT PROVIDED BY THE TRIGGER VALUE MAY TERMINATE ON THE FINAL REVIEW DATE — |
If the Final Value of any Index is less than
its Trigger Value and the notes have not been redeemed early, the benefit provided by the Trigger Value will terminate and you will be
fully exposed to any depreciation of the Least Performing Index.
| · | THE OPTIONAL EARLY REDEMPTION FEATURE MAY FORCE A POTENTIAL EARLY EXIT — |
If we elect to redeem your notes early, the
term of the notes may be reduced to as short as approximately three months and you will not receive any Contingent Interest Payments after
the applicable Interest Payment Date. There is no guarantee that you would be able to reinvest the proceeds from an investment in the
notes at a comparable return and/or with a comparable interest rate for a similar level of risk. Even in cases where we elect to redeem
your notes before maturity, you are not entitled to any fees and commissions described on the front cover of this pricing supplement.
PS-6
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
| · | YOU WILL NOT RECEIVE DIVIDENDS ON THE SECURITIES INCLUDED IN ANY INDEX OR HAVE ANY RIGHTS WITH RESPECT TO THOSE SECURITIES. |
| · | THE RISK OF THE CLOSING LEVEL OF AN INDEX FALLING BELOW ITS INTEREST BARRIER OR TRIGGER VALUE IS GREATER IF THE LEVEL OF THAT INDEX
IS VOLATILE. |
| · | WE MAY ACCELERATE YOUR NOTES IF A CHANGE-IN-LAW EVENT OCCURS — |
Upon the announcement or occurrence of legal
or regulatory changes that the calculation agent determines are likely to interfere with your or our ability to transact in or hold the
notes or our ability to hedge or perform our obligations under the notes, we may, in our sole and absolute discretion, accelerate the
payment on your notes and pay you an amount determined in good faith and in a commercially reasonable manner by the calculation agent.
If the payment on your notes is accelerated, your investment may result in a loss and you may not be able to reinvest your money in a
comparable investment. Please see “General Terms of Notes — Consequences of a Change-in-Law Event” in the accompanying
product supplement for more information.
The notes will not be listed on any securities
exchange. Accordingly, the price at which you may be able to trade your notes is likely to depend on the price, if any, at which JPMS
is willing to buy the notes. You may not be able to sell your notes. The notes are not designed to be short-term trading instruments.
Accordingly, you should be able and willing to hold your notes to maturity.
| · | THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED IN THE PRICING SUPPLEMENT — |
You should consider your potential investment
in the notes based on the minimums for the estimated value of the notes and the Contingent Interest Rate.
Risks Relating to Conflicts of Interest
We and our affiliates play a variety of roles
in connection with the notes. In performing these duties, our and JPMorgan Chase & Co.’s economic interests are potentially
adverse to your interests as an investor in the notes. It is possible that hedging or trading activities of ours or our affiliates in
connection with the notes could result in substantial returns for us or our affiliates while the value of the notes declines. Please refer
to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying product supplement.
Risks Relating to the Estimated Value and Secondary
Market Prices of the Notes
| · | THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES — |
The estimated value of the notes is only an
estimate determined by reference to several factors. The original issue price of the notes will exceed the estimated value of the notes
because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These
costs include the selling commissions, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent
in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. See “The Estimated
Value of the Notes” in this pricing supplement.
| · | THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE VALUES OF THE NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES —
|
See “The Estimated Value of the Notes”
in this pricing supplement.
| · | THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO AN INTERNAL FUNDING RATE — |
The internal funding rate used in the determination
of the estimated value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar
maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’
view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes
in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based
on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement
funding rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the
terms of the notes and any secondary market prices of the notes. See “The Estimated Value of the Notes” in this pricing supplement.
PS-7
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
| · | THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE
THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD — |
We generally expect that some of the costs included
in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in
an amount that will decline to zero over an initial predetermined period. See “Secondary Market Prices of the Notes” in this
pricing supplement for additional information relating to this initial period. Accordingly, the estimated value of your notes during this
initial period may be lower than the value of the notes as published by JPMS (and which may be shown on your customer account statements).
| · | SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER THAN THE ORIGINAL ISSUE PRICE OF THE NOTES — |
Any secondary market prices of the notes will
likely be lower than the original issue price of the notes because, among other things, secondary market prices take into account our
internal secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions,
projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the notes. As a result,
the price, if any, at which JPMS will be willing to buy the notes from you in secondary market transactions, if at all, is likely to be
lower than the original issue price. Any sale by you prior to the Maturity Date could result in a substantial loss to you.
| · | SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY MANY ECONOMIC AND MARKET FACTORS — |
The secondary market price of the notes during
their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the
selling commissions, projected hedging profits, if any, estimated hedging costs and the levels of the Indices. Additionally, independent
pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on customer account statements.
This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may be willing to purchase your notes
in the secondary market. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Notes
— Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying product supplement.
Risks Relating to the Indices
| · | AN INVESTMENT IN THE NOTES IS SUBJECT TO RISKS ASSOCIATED WITH SMALL CAPITALIZATION STOCKS WITH RESPECT TO THE RUSSELL 2000®
INDEX — |
Small capitalization companies may be less able
to withstand adverse economic, market, trade and competitive conditions relative to larger companies. Small capitalization companies are
less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that limits downward stock price
pressure under adverse market conditions.
| · | NON-U.S. SECURITIES RISK WITH RESPECT TO THE INDICES WITH RESPECT TO THE EURO STOXX 50® INDEX AND THE MSCI EMERGING
MARKETS INDEX — |
The equity
securities included in the EURO STOXX 50® Index and the MSCI Emerging Markets Index have
been issued by non-U.S. companies. Investments in securities linked to the value of such non-U.S. equity securities involve risks
associated with the securities markets in the home countries of the issuers of those non-U.S. equity securities. Also, there is
generally less publicly available information about companies in some of these jurisdictions than there is about U.S. companies that are
subject to the reporting requirements of the SEC.
| · | NO DIRECT EXPOSURE TO FLUCTUATIONS IN FOREIGN EXCHANGE RATES WITH RESPECT TO THE EURO STOXX 50® INDEX — |
The value of your notes will not be adjusted
for exchange rate fluctuations between the U.S. dollar and the currencies upon which the equity securities included in the EURO STOXX
50® Index are based, although any currency fluctuations could affect the performance of the EURO STOXX 50®
Index.
| · | EMERGING MARKETS RISK WITH RESPECT TO THE MSCI EMERGING MARKETS INDEX — |
The equity securities included in the MSCI Emerging
Markets Index have been issued by non-U.S. companies located in emerging markets countries. Countries with emerging markets may
have relatively unstable governments, may present the risks of nationalization of businesses, restrictions on foreign ownership and prohibitions
on the repatriation of assets, and may have less protection of property rights than more developed countries. The economies of countries
with emerging markets may be based on only a few industries, may be highly vulnerable to changes in local or global trade conditions,
and may suffer from extreme and volatile debt burdens or inflation rates. Local securities markets may trade a small number of securities
and may be unable to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or
impossible at times.
PS-8
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
| · | THE NOTES ARE SUBJECT TO CURRENCY EXCHANGE RISK WITH RESPECT TO THE MSCI EMERGING MARKETS INDEX — |
Because the prices of the equity securities
included in the MSCI Emerging Markets Index are converted into U.S. dollars for purposes of calculating the level of the MSCI Emerging
Markets Index, holders of the notes will be exposed to currency exchange rate risk with respect to each of the currencies in which the
equity securities included in the MSCI Emerging Markets Index trade. Your net exposure will depend on the extent to which those currencies
strengthen or weaken against the U.S. dollar and the relative weight of equity securities included in the MSCI Emerging Markets Index
denominated in each of those currencies. If, taking into account the relevant weighting, the U.S. dollar strengthens against those currencies,
the value of the MSCI Emerging Markets Index will be adversely affected and any payment on the notes may be reduced.
| · | RECENT EXECUTIVE ORDERS MAY ADVERSELY AFFECT THE PERFORMANCE OF THE MSCI EMERGING MARKETS INDEX — |
Pursuant to recent executive orders, U.S. persons
are prohibited from engaging in transactions in, or possession of, publicly traded securities of certain companies that are determined
to be linked to the People’s Republic of China military, intelligence and security apparatus, or securities that are derivative
of, or are designed to provide investment exposure to, those securities. The sponsor of the MSCI Emerging Markets Index recently
removed the equity securities of a small number of companies from the MSCI Emerging Markets Index in response to these executive orders.
If the issuer of any of the equity securities included in the MSCI Emerging Markets Index is in the future designated as such a prohibited
company, the value of that company may be adversely affected, perhaps significantly, which would adversely affect the performance of the
MSCI Emerging Markets Index. In addition, under these circumstances, the sponsor of the MSCI Emerging Markets Index is expected
to remove the equity securities of that company from the MSCI Emerging Markets Index. Any changes to the composition of the MSCI
Emerging Markets Index in response to these executive orders could adversely affect the performance of the MSCI Emerging Markets Index.
PS-9
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
The Indices
The Russell 2000® Index consists of
the middle 2,000 companies included in the Russell 3000E™ Index and, as a result of the index calculation methodology, consists
of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 2000® Index is designed
to track the performance of the small capitalization segment of the U.S. equity market. For additional information about the Russell 2000®
Index, see “Equity Index Descriptions — The Russell Indices” in the accompanying underlying supplement.
The EURO STOXX 50® Index consists of
50 component stocks of market sector leaders from within the Eurozone. The EURO STOXX 50® Index and STOXX are the intellectual
property (including registered trademarks) of STOXX Limited, Zurich, Switzerland and/or its licensors (the “Licensors”), which
are used under license. The notes based on the EURO STOXX 50® Index are in no way sponsored, endorsed, sold or promoted
by STOXX Limited and its Licensors and neither STOXX Limited nor any of its Licensors shall have any liability with respect thereto. For
additional information about the EURO STOXX 50® Index, see “Equity Index Descriptions — The STOXX Benchmark
Indices” in the accompanying underlying supplement.
The MSCI Emerging Markets Index is a free float-adjusted
market capitalization index that is designed to measure the equity market performance of global emerging markets. For additional information
about the MSCI Emerging Markets Index, see “Equity Index Descriptions — The MSCI Indices” in the accompanying underlying
supplement.
Historical Information
The following graphs set forth the historical performance
of each Index based on the weekly historical closing levels from January 4, 2019 through July 12, 2024. The closing level of the Russell
2000® Index on July 16, 2024 was 2,263.674. The closing level of the EURO STOXX 50® Index on July 16, 2024
was 4,947.83. The closing level of the MSCI Emerging Markets Index on July 16, 2024 was 1,117.38. We obtained the closing levels above
and below from the Bloomberg Professional® service (“Bloomberg”), without independent verification.
The historical closing levels of each Index should
not be taken as an indication of future performance, and no assurance can be given as to the closing level of any Index on any Review
Date. There can be no assurance that the performance of the Indices will result in the return of any of your principal amount or the payment
of any interest.
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_005.jpg)
PS-10
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_007.jpg)
Tax Treatment
You should review carefully the section entitled “Material
U.S. Federal Income Tax Consequences” in the accompanying product supplement no. 4-I. In determining our reporting responsibilities
we intend to treat (i) the notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons
and (ii) any Contingent Interest Payments as ordinary income, as described in the section entitled “Material U.S. Federal Income
Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward Contracts with Associated Contingent
Coupons” in the accompanying product supplement. Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel,
we believe that this is a reasonable treatment, but that there are other reasonable treatments that the IRS or a court may adopt, in which
case the timing and character of any income or loss on the notes could be materially affected. In addition, in 2007 Treasury and the IRS
released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar
instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their
investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments
and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests
comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration
of these issues could materially affect the tax consequences of an investment in the notes, possibly with retroactive effect. The discussions
above and in the accompanying product supplement do not address the consequences to taxpayers subject to special tax accounting rules
under Section 451(b) of the Code. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment
in the notes, including possible alternative treatments and the issues presented by the notice described above.
PS-11
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
Non-U.S. Holders — Tax Considerations.
The U.S. federal income tax treatment of Contingent Interest Payments is uncertain, and although we believe it is reasonable to take a
position that Contingent Interest Payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is provided), it
is expected that withholding agents will (and we, if we are the withholding agent, intend to) withhold on any Contingent Interest Payment
paid to a Non-U.S. Holder generally at a rate of 30% or at a reduced rate specified by an applicable income tax treaty under an “other
income” or similar provision. We will not be required to pay any additional amounts with respect to amounts withheld.
In order to claim an exemption from, or a reduction in, the 30% withholding tax, a Non-U.S. Holder of the notes must comply with certification
requirements to establish that it is not a U.S. person and is eligible for such an exemption or reduction under an applicable tax treaty.
If you are a Non-U.S. Holder, you should consult your tax adviser regarding the tax treatment of the notes, including the possibility
of obtaining a refund of any withholding tax and the certification requirement described above.
Section 871(m) of the Code and Treasury regulations
promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax (unless an income tax treaty applies) on
dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or
indices that include U.S. equities. Section 871(m) provides certain exceptions to this withholding regime, including for instruments linked
to certain broad-based indices that meet requirements set forth in the applicable Treasury regulations. Additionally, a recent IRS notice
excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a delta of one with respect to
underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an “Underlying Security”).
Based on certain determinations made by us, we expect that Section 871(m) will not apply to the notes with regard to Non-U.S. Holders.
Our determination is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application
may depend on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security.
If necessary, further information regarding the potential application of Section 871(m) will be provided in the pricing supplement for
the notes. You should consult your tax adviser regarding the potential application of Section 871(m) to the notes.
In the event of any withholding on the notes, we
will not be required to pay any additional amounts with respect to amounts so withheld.
The Estimated
Value of the Notes
The estimated value of the notes set forth on the
cover of this pricing supplement is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component
with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying
the economic terms of the notes. The estimated value of the notes does not represent a minimum price at which JPMS would be willing to
buy your notes in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated
value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by
JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’ view of
the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison
to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain
market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding
rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms
of the notes and any secondary market prices of the notes. For additional information, see “Selected Risk Considerations —
Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — The Estimated Value of the Notes Is Derived by
Reference to an Internal Funding Rate” in this pricing supplement.
The value of the derivative or derivatives underlying
the economic terms of the notes is derived from internal pricing models of our affiliates. These models are dependent on inputs such as
the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which
can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments.
Accordingly, the estimated value of the notes is determined when the terms of the notes are set based on market conditions and other relevant
factors and assumptions existing at that time.
The estimated value of the notes does not represent
future values of the notes and may differ from others’ estimates. Different pricing models and assumptions could provide valuations
for the notes that are greater than or less than the estimated value of the notes. In addition, market conditions and other relevant factors
in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the notes could change significantly
based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.’s creditworthiness, interest rate movements
and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy notes from you in secondary market
transactions.
The estimated value of the notes will be lower than
the original issue price of the notes because costs associated with selling, structuring and hedging the notes are included in the original
issue price of the notes. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the projected
profits, if any, that our affiliates expect to realize for assuming
PS-12
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
risks inherent in hedging our obligations under the
notes and the estimated cost of hedging our obligations under the notes. Because hedging our obligations entails risk and may be influenced
by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss.
A portion of the profits, if any, realized in hedging our obligations under the notes may be allowed to other affiliated or unaffiliated
dealers, and we or one or more of our affiliates will retain any remaining hedging profits. See “Selected Risk Considerations —
Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — The Estimated Value of the Notes Will Be Lower
Than the Original Issue Price (Price to Public) of the Notes” in this pricing supplement.
Secondary
Market Prices of the Notes
For information about factors that will impact any
secondary market prices of the notes, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices
of the Notes — Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying
product supplement. In addition, we generally expect that some of the costs included in the original issue price of the notes will be
partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial
predetermined period. These costs can include selling commissions, projected hedging profits, if any, and, in some circumstances, estimated
hedging costs and our internal secondary market funding rates for structured debt issuances. This initial predetermined time period is
intended to be the shorter of six months and one-half of the stated term of the notes. The length of any such initial period reflects
the structure of the notes, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs
of hedging the notes and when these costs are incurred, as determined by our affiliates. See “Selected Risk Considerations —
Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — The Value of the Notes as Published by JPMS (and
Which May Be Reflected on Customer Account Statements) May Be Higher Than the Then-Current Estimated Value of the Notes for a Limited
Time Period” in this pricing supplement.
Supplemental
Use of Proceeds
The notes are offered to meet investor demand for products
that reflect the risk-return profile and market exposure provided by the notes. See “How the Notes Work” and “Hypothetical
Payout Examples” in this pricing supplement for an illustration of the risk-return profile of the notes and “The Indices”
in this pricing supplement for a description of the market exposure provided by the notes.
The original issue price of the notes is equal to the
estimated value of the notes plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, plus (minus) the
projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes,
plus the estimated cost of hedging our obligations under the notes.
Additional
Terms Specific to the Notes
You may revoke your offer to purchase the notes at
any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of,
or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, we will notify
you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which
case we may reject your offer to purchase.
You should read this pricing supplement together with
the accompanying prospectus, as supplemented by the accompanying prospectus supplement relating to our Series A medium-term notes of which
these notes are a part, the accompanying prospectus addendum and the more detailed information contained in the accompanying product supplement
and the accompanying underlying supplement. This pricing supplement, together with the documents listed below, contains the terms of the
notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or
indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures or other
educational materials of ours. You should carefully consider, among other things, the matters set forth in the “Risk Factors”
sections of the accompanying prospectus supplement and the accompanying product supplement and in Annex A to the accompanying prospectus
addendum, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal,
tax, accounting and other advisers before you invest in the notes.
You may access these documents on the SEC website at
www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):
PS-13
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
Our Central Index Key, or CIK, on the SEC website is
1665650, and JPMorgan Chase & Co.’s CIK is 19617. As used in this pricing supplement, “we,” “us” and
“our” refer to JPMorgan Financial.
PS-14
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the Russell 2000® Index, the EURO STOXX 50® Index and the MSCI Emerging Markets Index |
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024062213/image_001.jpg) |
JP Morgan Chase (NYSE:JPM-M)
過去 株価チャート
から 6 2024 まで 7 2024
JP Morgan Chase (NYSE:JPM-M)
過去 株価チャート
から 7 2023 まで 7 2024